DUBLIN, Ohio, Aug. 7, 2019 /PRNewswire/ -- Cardinal Health
(NYSE: CAH) today announced that Dean
Scarborough, former Chairman and Chief Executive Officer of
Avery Dennison Corporation, and John Weiland, former Vice
Chairman, President and Chief Operating Officer of C.R. Bard,
Inc., will join its Board of Directors effective September 1. Mr. Scarborough and Mr. Weiland are
highly accomplished executives with decades of extraordinary
experience leading major global corporations.
These appointments will bring the total number of Cardinal
Health directors to 12, 11 of whom will be independent. Both Mr.
Scarborough and Mr. Weiland will serve as members of Cardinal
Health's Audit Committee.
"We are pleased to welcome Dean
Scarborough and John Weiland
to Cardinal Health's Board of Directors," said Gregory Kenny, Chairman of the Board. "Dean and
John are exceptionally well-regarded and accomplished leaders with
significant board experience, deep expertise and outstanding track
records having led industry-leading corporations. In addition, Dean
brings to our Board extensive knowledge in global manufacturing and
distribution while John brings a highly successful background in
healthcare and medical products. We look forward to their valuable
insights and judgment in helping us to successfully execute our
long-term strategic growth plans."
Dean Scarborough – Brief Bio
During his distinguished 35-year career with Avery Dennison, Mr. Scarborough held key
leadership roles including Chairman of the Board, Chief Executive
Officer and, before that, President and Chief Operating Officer. He
served as Avery Dennison's Chief
Executive Officer for 11 years from 2005 to 2016 and remained
Chairman of the Board until April of this year. Having joined
Avery Dennison in 1983, Mr.
Scarborough served in a series of leadership roles both in
the United States and abroad until
he was appointed Chief Operating Officer in 2000 and later Chief
Executive Officer.
Mr. Scarborough's tenure as Avery
Dennison's Chief Executive Officer was defined by profitable
growth and shareholder value creation through active portfolio
management, global leadership, as well as productivity, innovation
and sustainability initiatives. In addition, as President and Chief
Operating Officer, he led key initiatives to accelerate top-line
growth and directed the successful global implementation of Six
Sigma productivity improvement efforts across the company. Having
led Avery Dennison's global label
and packaging materials businesses, Mr. Scarborough brings
substantial experience in international manufacturing and
distribution operations.
Mr. Scarborough earned a Bachelor of Arts degree from
Hiram College and a Master of Business
Administration from the University of
Chicago. He currently serves on the Board of Directors of
Graphic Packaging Company and previously served on the Board of
Directors of Mattel for 11 years.
John Weiland – Brief Bio
Mr. Weiland brings more than 40 years of healthcare industry
experience. Most recently, he served as President and Chief
Operating Officer of medical device company C.R. Bard, Inc. (Bard)
from 2003 until his retirement in 2017, when Bard was acquired by
Becton, Dickinson and Company. In that role, he was responsible for
all of Bard's worldwide operations for 14 years. He also served on
Bard's Board of Directors from 2005 to 2017 and was named Vice
Chairman of the Board in 2016.
Prior to becoming Bard's president and Chief Operating Officer,
Mr. Weiland held the position of Group President, with global
responsibility for Bard Medical Division, Bard Urological Division,
Davol Inc., Bard Endoscopic Technologies Division and Bard's
Worldwide Manufacturing Operations. Before joining Bard in 1996,
Mr. Weiland served as Senior Vice President, North America Group
for Dentsply International and served as President and Chief
Executive Officer of Pharmacia Diagnostics, a division of Pharmacia
AB. He began his career at Baxter/American Hospital Supply.
In addition to his professional activities, Mr. Weiland is
actively involved in civic affairs. In 1987, he was named a White
House Fellow and served as Special Assistant to two members of
President Ronald Reagan's cabinet.
In 2012, he was the recipient of the distinguished Horatio Alger Award. Mr. Weiland graduated from
DeSales University with a Bachelor of
Science degree and earned a Master of Business Administration from
New York University.
Mr. Weiland also serves on the Board of Directors of Celgene
Corporation and previously held positions on the Boards of
Directors for West Pharmaceutical Services, Inc. and C.R. Bard,
Inc.
About Cardinal Health
Cardinal Health, Inc. is a
global, integrated healthcare services and products company,
providing customized solutions for hospitals, healthcare systems,
pharmacies, ambulatory surgery centers, clinical laboratories and
physician offices worldwide. The company enhances supply chain
efficiency for clinically proven medical products, pharmaceuticals
and cost-effective solutions. To combat prescription drug misuse,
the Cardinal Health Foundation and its education partners created
Generation Rx, a national drug prevention education and
awareness program. The Foundation actively supports an array of
other solutions, including efforts to reduce opioid
prescribing, promote drug take back and safe disposal and
expand collaborative community work. Cardinal Health is backed by
nearly 100 years of experience with operations in nearly 46
countries. For more information, visit cardinalhealth.com. Follow
us on Twitter, Facebook and LinkedIn.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/dean-scarborough-and-john-weiland-to-join-cardinal-healths-board-of-directors-300898368.html
SOURCE Cardinal Health